BCTX
Briacell Therapeutics
BCTX
BCTX
21 hedge funds and large institutions have $538K invested in Briacell Therapeutics in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
3
Closed
5
Calls
$157K
Puts
–
Net Calls
+$157K
Net Calls Change
+$51K
Top Buyers
| 1 |
Vontobel Holding
Zurich,
Switzerland
|
+$99.2K |
| 2 |
HF
HRT Financial
New York
|
+$92K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$33.4K |
| 4 |
LPL Financial
San Diego,
California
|
+$23.2K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$20K |
Top Sellers
| 1 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
-$131K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$20.3K |
| 3 |
Renaissance Technologies
New York
|
-$17.1K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$16.3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11K |
